Epiminder Company Description
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions.
The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp.
Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data.
The company was incorporated in 2017 and is based in Melbourne, Australia.
| Country | Australia |
| Founded | 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Rohan Hoare |
Contact Details
Address: West Podium, Mezzanine 2 Melbourne, VIC 3000 Australia | |
| Phone | 61 4 5252 1634 |
| Website | epiminder.com |
Stock Details
| Ticker Symbol | EPI |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000432239 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Rohan J. Hoare Ph.D. | Chief Executive Officer, MD and Director |
| Prof. Mark Cook A.O. | Founder and Chief Medical Officer |
| Mark McLellan | Chief Financial Officer and Company Secretary |
| Dr. John Heasman | Chief Operating Officer |
| Toby McSweeney | Chief Technology Officer |
| Belinda Ann Cleminson BEd, GIA (Cert) | Joint Company Secretary |